Alphabet offshoot Isomorphic Labs aims to use the Nobel Prize-winning protein-modelling tool AlphaFold to develop new medicines. Thrive Capital pursued the previously closed startup for 18 months, seeking a stake despite Isomorphic not actively raising funds.